2021 Annual Meeting Foot & Ankle Access Pass-Osteochondral Autograft Transplantation with Micronized Allograft Cartilage Matrix Augmentation

Osteochondral Autograft Transplantation with Micronized Allograft Cartilage Matrix Augmentation

Video Transcription

Video Summary

In this video, a medical student researcher from NYU Langone Orthopedic Hospital discusses osteochondral lesions of the talus (OLTs) and the surgical approaches used to treat them. The main focus is on augmentation with EMCA (a brand name biocartilage) and CBMA (concentrated bone marrow aspirate) as potential treatments for OLTs. The study compares the outcomes of AOT-CBMA alone versus AOT-CBMA augmented with EMCA. The study found that while both groups showed improved functional scores, there were no significant differences between them. Complications such as re-operations and arthroscopic debridements were reported in both groups. The limitations of the study include its retrospective nature and different follow-up times for each group. Overall, AOT-CBMA augmented with EMCA was shown to be an effective surgical treatment for OLTs, but CBMA alone may be sufficient for bone healing and cartilage incorporation.

Asset Caption

Dr. Alan Samsonov

Keywords

osteochondral lesions of the talus

surgical approaches

EMCA

CBMA

AOT-CBMA